Scienture Holdings (SCNX) Stock Price, Quote, News & History

Q: What sector and industry does Scienture Holdings (SCNX) operate in?

Scienture Holdings is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

Scienture Holdings Inc (SCNX) Stock Price, Quote, News & History

SCNXNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$0.4776

0.047611.07%

At close: Feb 6, 4:00 PM EST

$0.4693

-0.0083-1.74%

After Hours: 7:13 PM EST

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$0.43

$0.48

Volume / Avg.

483.45K / 1.92M

Day Range

$0.43 - $0.48

52 Wk Range

0.42 - 3.70

Market Cap

$19.07M

P/E Ratio

0.57

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

10.37%

Days to Cover

1.57

Recent Scienture Holdings Inc News

EXCLUSIVE: Penny Stock Scienture's Partner Secures US Patent For Highest Dosage Naloxone Spray For Emergency Opioid Overdose Treatment

New US patent strengthens protection for Rezenopy, the FDA-approved 10 mg naloxone nasal spray.

Vandana Singh

Why Is Scienture Stock Gaining Today?

Scienture stock is climbing after the company partnered with BlinkRx to expand national access to its new FDA-approved liquid losartan therapy, Arbli.

Nabaparna Bhattacharya

EXCLUSIVE: Scienture Delivers Q3 Revenue Jump With Arbli Sales And Debt Reduction

Scienture's Q3 revenue surged on Arbli sales, debt dropped, and cash rose to $8 million ahead of its planned Rezenopy launch in early 2026.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-11.11M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

11.04M

Free Cash Flow (TTM)

-11.10M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-71.82K

Valuation Metrics

Enterprise Value

$21.67M

PE Ratio (TTM)

0.57

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

8.42

PB Ratio (TTM)

0.21

Earnings Yield % (TTM)

176.43%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$2.03

Company Debt

Total Debt

$2.53M

LT Debt

LT Debt Issuance (TTM)

$2.79M

LT Debt Repayment (TTM)

-$3.33M

Total Cash

$355.69K

Debt to Equity

0.03

Issuance of Debt (TTM)

-$543.33K

Repayment of Debt (TTM)

-$3.33M

Key Statistics

Open

$0.43

$0.48

Volume / Avg.

483.45K / 1.92M

Day Range

$0.43 - $0.48

52 Wk Range

0.42 - 3.70

Market Cap

$19.07M

P/E Ratio

0.57

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

10.37%

Days to Cover

1.57

About

Sector

Health Care

Industry

Health Care Technology

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescrip...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Scienture Holdings (SCNX) stock?

You can purchase shares of Scienture Holdings (NASDAQ:SCNX) through any online brokerage.

View our list of the best stock brokerages

Who are Scienture Holdings (SCNX) competitors?

Other companies in Scienture Holdings’s space includes: OptimizeRx Corp (NASDAQ:OPRX), Definitive Healthcare Corp (NASDAQ:DH), Aclarion Inc (NASDAQ:ACONW), Bullfrog AI Holdings Inc (NASDAQ:BFRG) and CareCloud Inc (NASDAQ:CCLD).

What is the forecast, or price target, for Scienture Holdings (SCNX) stock?

There is no analysis for Scienture Holdings to provide a consensus price target.

What is the current price for Scienture Holdings (SCNX)?

The stock price for Scienture Holdings (NASDAQ: SCNX) is $0.4693 last updated February 6, 2026 at 7:13 PM EST.

Does Scienture Holdings (SCNX) pay a dividend?

There are no upcoming dividends for Scienture Holdings.

When is Scienture Holdings (NASDAQ:SCNX) reporting earnings?

Scienture Holdings does not have any upcoming earnings scheduled.

Is Scienture Holdings (SCNX) going to split?

There is no upcoming split for Scienture Holdings.

What sector and industry does Scienture Holdings (SCNX) operate in?

Scienture Holdings is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

People Also Watch

OptimizeRx Corp

NASDAQ:OPRX

$10.89

Definitive Healthcare Corp

Bullfrog AI Holdings Inc

Healthcare Triangle Inc

NASDAQ:HCTI

$0.16

3.11%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$0.43

$0.48

Volume / Avg.

483.45K / 1.92M

Day Range

$0.43 - $0.48

52 Wk Range

0.42 - 3.70

Market Cap

$19.07M

P/E Ratio

0.57

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

10.37%

Days to Cover

1.57

Recent Scienture Holdings Inc News

EXCLUSIVE: Penny Stock Scienture's Partner Secures US Patent For Highest Dosage Naloxone Spray For Emergency Opioid Overdose Treatment

New US patent strengthens protection for Rezenopy, the FDA-approved 10 mg naloxone nasal spray.

Vandana Singh

Why Is Scienture Stock Gaining Today?

Scienture stock is climbing after the company partnered with BlinkRx to expand national access to its new FDA-approved liquid losartan therapy, Arbli.

Nabaparna Bhattacharya

EXCLUSIVE: Scienture Delivers Q3 Revenue Jump With Arbli Sales And Debt Reduction

Scienture's Q3 revenue surged on Arbli sales, debt dropped, and cash rose to $8 million ahead of its planned Rezenopy launch in early 2026.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-11.11M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

11.04M

Free Cash Flow (TTM)

-11.10M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-71.82K

Valuation Metrics

Enterprise Value

$21.67M

PE Ratio (TTM)

0.57

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

8.42

PB Ratio (TTM)

0.21

Earnings Yield % (TTM)

176.43%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$2.03

Company Debt

Total Debt

$2.53M

LT Debt

LT Debt Issuance (TTM)

$2.79M

LT Debt Repayment (TTM)

-$3.33M

Total Cash

$355.69K

Debt to Equity

0.03

Issuance of Debt (TTM)

-$543.33K

Repayment of Debt (TTM)

-$3.33M

Key Statistics

Open

$0.43

$0.48

Volume / Avg.

483.45K / 1.92M

Day Range

$0.43 - $0.48

52 Wk Range

0.42 - 3.70

Market Cap

$19.07M

P/E Ratio

0.57

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

10.37%

Days to Cover

1.57

About

Sector

Health Care

Industry

Health Care Technology

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry